We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gottlieb said regulatory agencies and policymakers should take a consistent approach for all in vitro clinical tests regardless of whether they are developed by a traditional manufacturer or a clinical laboratory. Read More
FDA Commissioner Scott Gottlieb and CDRH Director Jeff Shuren hailed the “reimagination” of health care delivery through mobile medical apps and cited steps the agency is taking to encourage innovations in the rapidly developing market. Read More
India’s Central Drugs Standard Control Organization is calling on Johnson & Johnson to compensate patients who suffered serious adverse events linked to the company’s ASR hip implants. Read More
NHS said the code will provide the basis for digital technology suppliers to enter into arrangements with technology companies and healthcare providers. Read More
The FDA issued two new guidances for sponsors of products designed to treat hay fever as well as other cold-like symptoms that aren’t caused by allergies — and said it considers the delivery system for a topical drug as part of its review, so the whole product is evaluated as a hybrid drug/device. Read More